申请人:Roberts Michael Stanley
公开号:US20060252839A1
公开(公告)日:2006-11-09
A compound comprising a cyclopentanone, cyclopentenone, cyclohexanone or cyclohexenone group, wherein a first ring carbon atom carries an —SR substituent, R is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group that, optionally, includes at least one heteroatom in its carbon skeleton, the remaining available ring carbon atoms are optionally substituted, and said compound either:—(a) is more soluble in water at a temperature of 20-40° C.; (b) is less lipophilic; and/or, (c) has a greater therapeutic index; or; (d) is less soluble in water at a temperature of 20-40° C.; (e) is more lipophilic; and/or, (f) has a greater therapeutic index; than an equivalent cyclohex-2-en-1-one or cyclopent-2-en-1-one derivative in which a hydrogen atom replaces said —SR group.
一种化合物,包括环戊酮,环戊烯酮,环己酮或环己烯酮基团,其中第一个环碳原子带有—SR取代基,R是取代或未取代的烷基,烯基,炔基,芳基,芳基烷基,芳基烯基或芳基炔基,可选地,在其碳骨架中包括至少一个杂原子,其余可用的环碳原子可选地被取代,所述化合物:(a)在20-40°C的温度下更易溶于水;(b)更不亲脂性;和/或(c)具有更高的治疗指数;或者;(d)在20-40°C的温度下更不易溶于水;(e)更亲脂性;和/或(f)具有更高的治疗指数;比相应的氢原子取代了所述—SR基团的环己-2-烯-1-酮或环戊-2-烯-1-酮衍生物。